Skip to main content
EDIT logo

EDIT · Editas Medicine, Inc. · Analyst Estimates

Track EDIT — free
$2.62 +0.10 (+3.97%) At close · Oct 2
Market Cap
$396.24M
Shares
153.58M
Volume · Oct 2 2.16M Avg daily vol (3M) 2.47M

Analyst Estimates

Compare analyst forecasts for Editas Medicine, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-24 19:10 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.99
-0.82929
-0.66
—
-0.9961
-0.9961
-0.99412
-0.98983
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
5
5
Revenue
USD
Publication date not stated
16721000
25794170
38900000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.85
-0.75313
-0.59598
—
-0.93645
-0.93645
-0.95595
-0.90595
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
5
5
Revenue
USD
Publication date not stated
2000000
19458650
39334000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.25
-0.20614
-0.18737
—
-0.27875
-0.27875
-0.28
-0.27143
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
0
0
6
6
Revenue
USD
Publication date not stated
500000
4534520
12009000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.28
-0.20857
-0.08
—
-0.23895
-0.23895
-0.2388
-0.25452
— — — —
EPS
analysts
Publication date not stated
— — —
7
— — — —
1
1
5
5
Revenue
USD
Publication date not stated
1000000
6520730
20000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
12
— — — — — — — —
Key facts CIK 1650664 CUSIP 28106W103 13F (30d) 4 filings 4 filers Visit website Investor relations